日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bacillus subtilis Uncharacterized protein yqhL (yqhL), partial CSB-YP344978BRJ
CSB-EP344978BRJ
CSB-BP344978BRJ
CSB-MP344978BRJ
CSB-EP344978BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yqhR (yqhR), partial CSB-YP344979BRJ1
CSB-EP344979BRJ1
CSB-BP344979BRJ1
CSB-MP344979BRJ1
CSB-EP344979BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Exodeoxyribonuclease 7 large subunit (xseA) CSB-YP344980BRJ
CSB-EP344980BRJ
CSB-BP344980BRJ
CSB-MP344980BRJ
CSB-EP344980BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein YqiI (yqiI) CSB-YP344981BRJ
CSB-EP344981BRJ
CSB-BP344981BRJ
CSB-MP344981BRJ
CSB-EP344981BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Arginine transport system permease protein ArtQ (artQ), partial CSB-YP344982BRJ1
CSB-EP344982BRJ1
CSB-BP344982BRJ1
CSB-MP344982BRJ1
CSB-EP344982BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Putative propionyl-CoA carboxylase beta chain (yqjD), partial CSB-YP344983BRJ
CSB-EP344983BRJ
CSB-BP344983BRJ
CSB-MP344983BRJ
CSB-EP344983BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yqjP (yqjP) CSB-YP344984BRJ
CSB-EP344984BRJ
CSB-BP344984BRJ
CSB-MP344984BRJ
CSB-EP344984BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis DNA polymerase IV 2 (dinB2) CSB-YP344985BRJ
CSB-EP344985BRJ
CSB-BP344985BRJ
CSB-MP344985BRJ
CSB-EP344985BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Malate-2H (+)/Na (+)-lactate antiporter, partial CSB-YP344986BRJ
CSB-EP344986BRJ
CSB-BP344986BRJ
CSB-MP344986BRJ
CSB-EP344986BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yhcE (yhcE), partial CSB-YP344987BRJ1
CSB-EP344987BRJ1
CSB-BP344987BRJ1
CSB-MP344987BRJ1
CSB-EP344987BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yhcI (yhcI), partial CSB-YP344988BRJ1
CSB-EP344988BRJ1
CSB-BP344988BRJ1
CSB-MP344988BRJ1
CSB-EP344988BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yhcS (yhcS), partial CSB-YP344989BRJ
CSB-EP344989BRJ
CSB-BP344989BRJ
CSB-MP344989BRJ
CSB-EP344989BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis UPF0012 hydrolase yhcX (yhcX), partial CSB-YP344990BRJ
CSB-EP344990BRJ
CSB-BP344990BRJ
CSB-MP344990BRJ
CSB-EP344990BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Enoyl-[acyl-carrier-protein] reductase [NADH] FabI (fabI) CSB-YP344991BRJ
CSB-EP344991BRJ
CSB-BP344991BRJ
CSB-MP344991BRJ
CSB-EP344991BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila erecta Trypsin alpha (alphaTry) CSB-YP344992DLK
CSB-EP344992DLK
CSB-BP344992DLK
CSB-MP344992DLK
CSB-EP344992DLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila erecta Trypsin theta (thetaTry) CSB-YP344993DLK
CSB-EP344993DLK
CSB-BP344993DLK
CSB-MP344993DLK
CSB-EP344993DLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lordsdale virus Genome polyprotein (ORF1), partial CSB-YP344994LIV
CSB-EP344994LIV
CSB-BP344994LIV
CSB-MP344994LIV
CSB-EP344994LIV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Acetylornithine deacetylase (argE) CSB-YP344995DKK
CSB-EP344995DKK
CSB-BP344995DKK
CSB-MP344995DKK
CSB-EP344995DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum RAC family serine/threonine-protein kinase homolog (pkbA) CSB-YP344996DKK
CSB-EP344996DKK
CSB-BP344996DKK
CSB-MP344996DKK
CSB-EP344996DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aggregatibacter actinomycetemcomitans Chaperone protein htpG (htpG), partial CSB-YP344997AYK
CSB-EP344997AYK
CSB-BP344997AYK
CSB-MP344997AYK
CSB-EP344997AYK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×